Connect your AI

BillionToOne, Inc. BLLN Common stock, capital shares reserved for future issuance

Common stock, capital shares reserved for future issuance at other companies

Guardant HealthGH

——

Other financials

Income statement

Revenue$108.4M+83.8%

Gross profit$79.1M+108%

Operating income$17.8M+870%

Net income$18.0M+551%

EPS (diluted)$0.34+187%

Balance sheet

Cash & equivalents$537.5M+181%

Total debt$144.2M—

Total equity$505.6M+300%

Total assets$700.7M—

Cash flow

Operating cash flow$15.4M+488%

CapEx$4.5M+90.5%

Free cash flow$11.0M+3,842%

Valuation

Market cap$4.96B+17.3%

Enterprise value$4.56B—

P/E167.1×—

P/S14×—

Profitability

Gross margin70.4%—

Operating margin-96.9%—

Net margin8.4%—

FCF margin-83.4%—

Returns & leverage

Return on equity23.5%—

Debt / equity0.3×—

Current ratio10.9×—

Where this comes from

Reported directly by BillionToOne, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.

The official record: BillionToOne, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BillionToOne, Inc. 's common stock, capital shares reserved for future issuance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is BillionToOne, Inc. 's common stock, capital shares reserved for future issuance?: BillionToOne, Inc. (BLLN) reported common stock, capital shares reserved for future issuance of $17.99M in Q1 2026.